ONCOLOGY · FOR SITES
Oncology clinical research has a direct and meaningful connection to patient access. For many patients, clinical trials represent an opportunity to contribute to science and potentially access innovative investigational approaches under structured medical oversight.
At BRCR Global, patient impact is central to our oncology mission. We work to connect research opportunities with patients, physicians, and communities while respecting the sensitivity, complexity, and urgency of oncology care.
Our oncology network is built around the idea that research should be accessible, ethical, clear, and supportive.
Why patient impact matters in oncology: Every oncology study has the potential to contribute to future treatment options, scientific knowledge, and improved understanding of disease. By strengthening access to trials, BRCR Global helps bring research closer to the people and communities it is meant to serve.
Value for patients and communities: A research environment that prioritizes dignity, communication, support, and access to clinical trial opportunities.
BRCR Global supports oncology and hematology clinical research through a combination of specialized site experience, investigator engagement, recruitment planning, and operational coordination.
Our capabilities are designed to support sponsors, CROs, investigators, and sites across different study phases, indications, and protocol requirements.
Our oncology capabilities include:
Oncology Site Network
Access to oncology-ready sites and investigators across strategic locations.
Hematology Experience
Support for hematologic malignancies and related study populations.
Patient Identification
EMR review, physician referrals, database searches, and community/medical network outreach.
Complex Eligibility Review
Support for studies with highly specific inclusion/exclusion criteria, prior lines of therapy, biomarkers, staging, treatment history, and documentation needs.
Referral Pathway Development
Medical networking with oncologists, hematologists, specialty physicians, and referring providers.
Recruitment Strategy
Protocol-specific recruitment plans based on indication, patient pathway, geographic access, and feasibility.
Retention Planning
Patient-centered follow-up to support study continuity, visit adherence, and communication.
Quality & Compliance
Processes aligned with GCP, sponsor requirements, SOPs, documentation standards, and participant safety.
BRCR Global's oncology and hematology experience may support a range of therapeutic indications depending on site capability, investigator experience, patient access, and sponsor needs.
Potential areas of focus include:
Our approach: Each protocol is evaluated individually to identify the right site, investigator, recruitment pathway, patient population, and operational strategy.
Oncology recruitment requires more than broad outreach. It requires precision.
Patients must often meet complex eligibility requirements related to diagnosis, staging, prior treatment, biomarkers, performance status, laboratory values, disease progression, comorbidities, and timing of therapy.
BRCR Global's oncology recruitment model is designed to identify candidates through a targeted, compliant, and medically aligned process.
Our oncology recruitment model includes:
EMR and Database Review
Structured searches to identify patients based on diagnosis, treatment history, staging, disease status, and protocol-specific criteria.
Investigator-Led Patient Identification
Engagement of PIs and Sub-Is in reviewing potential candidates and aligning clinical judgment with protocol requirements.
Referring Physician Network
Outreach to oncologists, hematologists, specialists, and community physicians who may identify potentially eligible patients.
Multidisciplinary Collaboration
Coordination between recruitment teams, CRCs, investigators, medical records, imaging, labs, and referring providers.
Patient-Friendly Communication
Clear, respectful communication that explains the study process without overpromising or creating unrealistic expectations.
Funnel Tracking
Dashboards to monitor leads, pre-screening, eligibility status, documentation needs, screen failures, and randomization outcomes.
Value for sponsors and CROs: A recruitment strategy that prioritizes qualified candidates, reduces unnecessary screen failures, and supports enrollment performance.
Quality is especially critical in oncology clinical trials, where protocols may involve complex procedures, specialized assessments, safety considerations, and detailed documentation.
BRCR Global's oncology execution model is built around training, oversight, documentation, protocol adherence, and continuous communication.
Our oncology quality approach includes:
Quality principle: In oncology research, precision protects patients, supports data integrity, and strengthens study reliability.
